NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.5906
-0.0189 (-3.10%)
At close: May 5, 2026, 4:00 PM EDT
0.5906
0.00 (0.00%)
Pre-market: May 6, 2026, 5:39 AM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $5.01 million as of May 6, 2026. Its market cap has decreased by -76.89% in one year.
Market Cap
5.01M
Enterprise Value
7.78M
1-Year Change
-76.89%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $5.01M, a decrease of -74.45%. That is a compound annual growth rate of -26.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 5.17M | -60.60% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 33.10M |
| Milestone Scientific | 29.88M |
| Harvard Bioscience | 28.68M |
| Femasys | 23.19M |
| Retractable Technologies | 18.92M |
| Jin Medical International | 18.16M |
| Regentis Biomaterials | 14.86M |
| Bionano Genomics | 13.09M |